Your Location：
Home >
Browse articles >
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
REVIEW | Updated：2025-12-13
Previous|Next

    • Targeting the epigenome to reinvigorate T cells for cancer immunotherapy

    • “In the field of cancer immunotherapy, researchers have summarized the epigenetic mechanisms leading to T cell exhaustion in the tumor microenvironment and discussed the therapeutic potential of targeting epigenetic regulators for immunotherapies. This lays a foundation for the construction of treatment paradigms involving immunostimulatory agents and epigenetic therapies.”
    • Dian Xiong , Lu Zhang , Zhi-Jun Sun
    • Military Medical Research Vol. 11, Issue 6, Pages: 863-886(2024)

    • DOI： 10.1186/s40779-023-00496-2     

      CLC：

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 4 ) Tabs( 1 )

  • References

  • Publication Info

  • Metrics

28

Views

38

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients
Frostbite: diagnosis, treatment, prognosis, and future directions

Related Author

No data

Related Institution

No data